Short‐Course TNT Improves Rectal Tumor Downstaging in a Retrospective Study of the US Rectal Cancer Consortium
Bauer P, Gamboa A, Otegbeye E, Chapman W, Rivard S, Regenbogen S, Hrebinko K, Holder‐Murray J, Wiseman J, Ejaz A, Edwards‐Hollingsworth K, Hawkins A, Hunt S, Balch G, Wise P. Short‐Course TNT Improves Rectal Tumor Downstaging in a Retrospective Study of the US Rectal Cancer Consortium. Journal Of Surgical Oncology 2024, 131: 498-506. PMID: 39400312, DOI: 10.1002/jso.27908.Peer-Reviewed Original ResearchLong-course chemoradiationPathological complete responseComplete responseCR rateTumor downstagingConsolidation chemotherapyRate of pathological complete responseNeoadjuvant long-course chemoradiationRate of complete responseClinically node-negative diseaseClinical complete responseShort-course radiationNode-negative diseaseSingle-center reviewMulti-institutional experiencePredictors of CRRAPIDO trialTNT patientsLow tumorsRectal adenocarcinomaRectal cancerNonoperative managementRetrospective studyCancer care centerNonoperative options
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply